4//SEC Filing
Bardin Stephen 4
Accession 0001415889-25-018309
CIK 0001534133other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:30 PM ET
Size
9.2 KB
Accession
0001415889-25-018309
Insider Transaction Report
Form 4
Bardin Stephen
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-06-24+20,000→ 20,000 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (20,000 underlying) - Purchase
Common Stock
2025-06-26$1.50/sh+2,000$3,005→ 3,000 total(indirect: See Footnote)
Holdings
- 40,000
Common Stock
Footnotes (6)
- [F1]The weighted average purchase price for the transaction reported was $1.5025, and the range of prices were between $1.45 and $1.54. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]Includes 1,000 shares held by The Bardin Family Trust dated June 4, 2024 (the "Trust") which were inadvertently reported as directly owned on the Form 4 filed with the SEC on June 3, 2025.
- [F3]By The Bardin Family Trust dated June 4, 2024.
- [F4]Excludes 1,000 shares held by the Trust which were inadvertently reported as directly owned on the Form 4 filed with the SEC on June 3, 2025.
- [F5]The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
- [F6]Immediately exercisable.
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
Related Parties
1- filerCIK 0001942596
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:30 PM ET
- Size
- 9.2 KB